Results 211 to 220 of about 141,408 (359)

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells

open access: yesHematological Oncology, Volume 40, Issue 5, Page 999-1008, December 2022., 2022
Abstract Mechanisms underlying interactions between a novel, clinically relevant circularized tumor necrosis factor‐related apoptosis inducing ligand (TRAIL) agonist, circularly permuted TRAIL (CPT) have been examined in multiple myeloma (MM) cells sensitive or resistant to bortezomib (BTZ).
Yun Leng   +11 more
wiley   +1 more source

Systemic circulating microRNA landscape in Lynch syndrome

open access: yesInternational Journal of Cancer, Volume 152, Issue 5, Page 932-944, 1 March 2023., 2023
What's new? Systemic circulating microRNA expression patterns (c‐miRnomes) are altered during sporadic carcinogenesis and they have predictive potential in early cancer detection. However, their potential in carriers of inherited pathogenic mismatch‐repair gene variants associated with Lynch syndrome remains understudied.
Tero Sievänen   +10 more
wiley   +1 more source

Plasticity of mitotic cyclins in promoting the G2-M transition. [PDF]

open access: yesJ Cell Biol
Crncec A   +7 more
europepmc   +1 more source

Cyclin B1 Expression in HeLa S3 Cells Studied by Flow Cytometry

open access: hybrid, 1994
Steven W. Sherwood   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy